Evidence map›Paper›PMID 37709930›Full record

ArticleNature materials2023

The laminin-keratin link shields the nucleus from mechanical deformation and signalling.

Zanetta Kechagia, Pablo Sáez, Manuel Gómez-González, Brenda Canales, Srivatsava Viswanadha, Martín Zamarbide, Ion Andreu, Thijs Koorman, Amy E M Beedle, Alberto Elosegui-Artola and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Nature materials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Integrin-Piezo1 Axis Drives ECM Remodeling and Invasion of 3D Breast Epithelium.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  15. Article
  16. MUC15 Ectodomain Architecture Regulates Integrin Clustering to Control Cancer Metastasis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 3 countries.

Zanetta KechagiaInstitute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. jkechagia@ibecbarcelona.eu.ORCID 0000-0002-1436-7538
Pablo SáezLaboratori de Càlcul Numèric (LàCaN), Universitat Politècnica de Catalunya, Barcelona, Spain.ORCID 0000-0002-9253-0417
Manuel Gómez-GonzálezInstitute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.ORCID 0000-0002-5091-0411
Brenda CanalesCell and Tissue Mechanobiology Laboratory, The Francis Crick Institute, London, UK.ORCID 0000-0002-1209-5540
Srivatsava ViswanadhaInstitute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Martín ZamarbideUniversity of Barcelona, Barcelona, Spain.
Ion AndreuInstitute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.ORCID 0000-0002-8374-152X
Thijs KoormanDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0002-6064-3353
Amy E M BeedleInstitute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Alberto Elosegui-ArtolaCell and Tissue Mechanobiology Laboratory, The Francis Crick Institute, London, UK.ORCID 0000-0003-0644-3294
Patrick W B DerksenDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0003-0732-7762
Xavier TrepatInstitute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.ORCID 0000-0002-7621-5214
Marino ArroyoInstitute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.ORCID 0000-0003-1647-940X
Pere Roca-CusachsInstitute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. proca@ibecbarcelona.eu.ORCID 0000-0001-6947-961X
Institute for Bioengineering of Catalonia · ESKing's College London · GBUniversity Medical Center Utrecht · NLFC Barcelona · ESIkerbasque · ESInstitució Catalana de Recerca i Estudis Avançats · ESInstitut Barcelona d'Estudis Internacionals · ESInternational Center for Numerical Methods in Engineering · ESUniversitat de Barcelona · ES

Funding

Wellcome Trust CC2214
6 · The paper itself

Abstract

The mechanical properties of the extracellular matrix dictate tissue behaviour. In epithelial tissues, laminin is a very abundant extracellular matrix component and a key supporting element. Here we show that laminin hinders the mechanoresponses of breast epithelial cells by shielding the nucleus from mechanical deformation. Coating substrates with laminin-111-unlike fibronectin or collagen I-impairs cell response to substrate rigidity and YAP nuclear localization. Blocking the laminin-specific integrin β4 increases nuclear YAP ratios in a rigidity-dependent manner without affecting the cell forces or focal adhesions. By combining mechanical perturbations and mathematical modelling, we show that β4 integrins establish a mechanical linkage between the substrate and keratin cytoskeleton, which stiffens the network and shields the nucleus from actomyosin-mediated mechanical deformation. In turn, this affects the nuclear YAP mechanoresponses, chromatin methylation and cell invasion in three dimensions. Our results demonstrate a mechanism by which tissues can regulate their sensitivity to mechanical signals.

Indexed as

KeratinsLamininCell AdhesionCytoskeletonExtracellular MatrixFibronectinsIntegrinsFibronectinsIntegrinsKeratinsLaminin

Identifiers

PMID37709930
PMCPMC10627833
OpenAlexW4386741095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.